Cytarabine Hydrochloride for Injection

Cytarabine injection, indicated for use with other cytostatics, is used to treat leukemia and lymphoma. Common dosage: – Induction of remission, consolidation and maintenance therapy for acute non-lymphocytic leukemia in adults and children – Induction of remission, consolidation and treatment for acute lymphocytic leukemia in adults and children – Intrathecal prevention and treatment of leukemia infiltration of the central nervous system. – Treatment of moderate and severe non-Hodgkin’s lymphoma in adults – Treatment of non-Hodgkin’s lymphoma in children – Treatment of blast crisis in chronic myeloid leukemia High-dose therapy: – Non-Hodgkin’s lymphoma resistant to other agents – Acute non-Hodgkin’s lymphoma resistant to other agents – Acute lymphoblastic leukemia resistant to other agents – Relapse of acute leukemia – Leukemia due to special causes (leukemia secondary to previous chemotherapy and/or radiotherapy, leukemia transformed from preleukemia) – Consolidation treatment of patients under 60 years of age in remission from acute non-lymphocytic leukemia – Blastic crisis in chronic myeloid leukemia